News

Does Idex (IEX) have what it takes to be a top stock pick for momentum investors? Let's find out.

AIT gains from MRO demand, acquisitions and shareholder returns, but rising costs and supply-chain issues remain key risks.

While IDEX has outperformed relative to its peers over the past 52 weeks, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

ITT is set to acquire Aerospace Contacts for about $31M, aiming to strengthen its supply chain, aerospace offerings and interconnect solutions portfolio.

SWK's Engineered Fastening segment is gaining from aerospace and automotive demand, while cost-saving efforts support profitability.

Here is how Idex (IEX) and TriMas (TRS) have performed compared to their sector so far this year.

RBC Bearings, IDEX, Watts Water and Helios Technologies are highlighted as industrial manufacturers benefiting from innovation and manufacturing growth.

How IDEX (IEX) stock has been moving IDEX (IEX) has seen modest price shifts recently, with the stock up slightly over the past week but down about 3% over the past month, leaving year to date returns near 18%. See our latest analysis for IDEX. Short term momentum has cooled, with a 1 month share price return of down 3%, but the year to date share price return of 17.74% and 1 year total shareholder return of 18.34% still point to resilient interest in the stock. If this kind of steady...

Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Rising manufacturing activity, technological advancements and strategic acquisitions are supporting the near-term outlook of the Zacks Manufacturing - General Industrial industry. RBC, IEX, WTS and HLIO are some promising stocks in the industry.

MarketAxess sits at the center of the shift toward electronic bond trading and investors are watching whether record activity is turning into deeper client reliance on its trading, data, and automation tools.

Here is how Idex (IEX) and Nordson (NDSN) have performed compared to their sector so far this year.

Although IDEX Corporation has underperformed the broader market over the past year, Wall Street analysts remain moderately optimistic about the company’s long-term growth prospects.

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

If you are wondering whether IDEX at around US$208 per share is offering good value today, it helps to step back and look at the drivers behind that price before jumping to any conclusions. The stock has slipped about 1.9% over the last 7 days, while the 30 day return is around 0.9% and both the year to date and 1 year returns sit at 16.3%. These figures can change how the risk and reward trade off feels for existing and potential shareholders. Recent coverage has focused on IDEX as a steady...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.

Is IEX a good stock to buy? We came across a bullish thesis on IDEX Corporation on Valueinvestorsclub.com by angus309. In this article, we will summarize the bulls’ thesis on IEX. IDEX Corporation’s share was trading at $214.93 as of May 1st. IEX’s trailing and forward P/E were 31.79 and 26.04 respectively according to Yahoo Finance. IDEX […]

IDEX (IEX) has drawn investor attention after recent trading, with the stock last closing at US$214.93 and showing positive returns over the past month and past 3 months. That performance now sits alongside a value score of 1. See our latest analysis for IDEX. While the share price slipped 1.3% over the last session, the 7 day share price return of 5.0% and year to date share price return of 20.0% suggest momentum has been building alongside a 1 year total shareholder return of 20.3%. If...

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".

IEX beats Q1 estimates and raises outlook as strong Health & Science Technologies demand and record orders signal momentum into 2026.

IDEX (NYSE:IEX) reported first-quarter 2026 results that management said came in above expectations, supported by growth in its targeted “advantage markets” and continued application of the company’s 80/20 operating philosophy. Quarterly performance and orders President and CEO Eric Ashleman said I

Moby summary of IDEX Corporation's Q1 2026 earnings call

IDEX delivered a strong first quarter and continue to see our growth strategies gain traction as we expand and integrate capabilities in targeted advantaged markets powered by 8020. In the first quarter, IDEX delivered organic sales growth of 5% and adjusted EBITDA margin of 26%, which reflects a margin expansion of 50 basis points year-over-year. Strength was most pronounced in our Health & Science Technologies, or HST segment, where secular drivers continue to fuel growth across high-value applications in data center, semiconductor and space and defense markets.

The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Idex (IEX) delivered earnings and revenue surprises of +12.68% and +6.20%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?